Wednesday, 26 August 2026European Markets

COFINA,SGPS Stock Impressive Rise On Monday, Outperforms Market

Loading stream...

(VIANEWS) - The Market ended the session with COFINA,SGPS (CFN.LS) rising 14.41% to €1.35 on Monday, after two successive sessions in a row of gains. PSI dropped 0.34% to €6,655.83, following the last session's downward trend on what was a somewhat negative trend exchanging session today.

COFINA,SGPS's last close was €1.18, 136% higher than its 52-week high of €0.50.

About COFINA,SGPS

Cofina, SGPS, S.A., through its subsidiaries, engages in the publication of newspapers and magazines in Portugal. The company offers newspapers, including Correio da Manha, a daily newspaper; Record, a daily sport newspaper; Negocios, an economic newspaper; and Destak, a free newspaper. It also provides Sábado, an entertainment weekly magazine; TV Guia, weekly television magazine; Máxima, an online publication that develops topics related to culture, fashion, beauty, health and well-being, and travel and lifestyle; Flash, an online publication which addresses the social current affairs of national and international public figures; and Correio da Manhã TV (cmTV), a cable platform. In addition, the company engages in the investment management activities. The company was incorporated in 1990 and is headquartered in Porto, Portugal.

Earnings Per Share

As for profitability, COFINA,SGPS has a trailing twelve months EPS of €-1.4.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -24.26%.

More news about COFINA,SGPS (CFN.LS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com